Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive ...

I'm a single mother of two children, an 8-year-old daughter and a 9-year-old son. My daughter's father is involved; my son's ...

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

VIENNA — Survival rates at 1 and 5 years for patients with pulmonary arterial hypertension (PAH ... for end-stage PAH remains an important treatment option. Heart-lung transplantation plummeted ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

Treatment of systolic hypertension in the ... No writing assistance was utilized in the production of this manuscript. Arterial hypertension in the elderly is a major health economy burden.